Faculty profile
Carolina Ilkow
Back to facultyResearch
Read how they describe their research on their University of Ottawa profile.
Latest funding
- $120,000
Strategies for inhibiting protein kinase R and antiviral effectors to increase the spread and persistence of self-amplifying RNA-based cancer vaccines using small molecules, short-hairpin RNA and viral microRNA.
CIHR · 2025 · Supervisor
- $120,000
Oncolytic Virus-Delivered miRNA: Targeting of Mutant KRAS in Cancer Therapy
CIHR · 2025 · Supervisor
- $140,000
Pharmacologic modulation of the hematopoietic progenitor kinase 1 (HPK1) to enhance cell-based immunotherapies in pancreatic ductal adenocarcinoma
CIHR · 2025 · Supervisor
No publications available.
Strategies for inhibiting protein kinase R and antiviral effectors to increase the spread and persistence of self-amplifying RNA-based cancer vaccines using small molecules, short-hairpin RNA and viral microRNA.
Principal investigators: Thomas, Dylan A
Keywords: Cancer Vaccines; Flow Cytometry; Immunotherapy; In-Vivo Mouse Models; Protein Kinase R; Rna Sequencing; Self-Amplifying Rna; Short Hairpin Rna; Tumour Microenvironment; Viral Microrna
Oncolytic Virus-Delivered miRNA: Targeting of Mutant KRAS in Cancer Therapy
Principal investigators: Rathod, Khushi
Keywords: Flow Cytometry; Immune Checkpoints; Immunotherapies; Kras; Micro-Rna; Oncogenes; Oncolytic Viruses; Pancreatic Cancer; Rna Interference; Tumour Samples
Pharmacologic modulation of the hematopoietic progenitor kinase 1 (HPK1) to enhance cell-based immunotherapies in pancreatic ductal adenocarcinoma
Principal investigators: Taha, Zaid
Keywords: Adoptive Cell Transfer; Cancer Immunotherapy; Hpk1; Tils; Vaccine
Accessible and affordable: Investigation of novel 'self-amplifying' mRNA delivery as cost-effective vaccine platforms for addressing future Canadian pandemic preparedness and health emergencies.
Principal investigators: Lee, Timothy K
Keywords: Cancer; Covid-19; Infectious Disease; Self-Amplifying Mrna; Systemic Immunity; Vaccine
Engineered Extracellular Vesicles to Enhance Immunotherapy in Immunosuppressive Non-Small Cell Lung Cancers
Principal investigators: Ilkow, Carolina S; Goss, Glenwood D
Keywords: Biotherapeutics; Extracellular Vesicles; Hard To Treat Cancers; Sting Pathway
Bringing Cancer Research from Bench to Bedside
Principal investigators: Dave, Jaahnavi; Auer, Rebecca Ann C
Keywords: Cancer Treatment; Immunotherapies; Knowledge Dissemination
Development and Clinical Testing of Effective Immunotherapies for Biliary Tract Cancers.
Principal investigators: Ilkow, Carolina S
Keywords: Biliary Track Cancers; Cancer-Killing Viruses; Cholangiocarcinoma; Hope; Immunoprofiling ; Immunotherapy; Multidisciplinary Approach; Nk Therapy ; Patient-Centric; Til Therapy
Designing oncolytic rhabdoviruses for horizontal delivery of artificial microRNAs
Principal investigators: Ilkow, Carolina S
Keywords: Extracellular Vesicles; Oncolytic Viruses; Therapeutics
Understanding the role of adipose tissue and fat cells in cancer virotherapy resistance
Principal investigators: Ilkow, Carolina S
Keywords: Immunotherapy; Metastasis; Oncolytic Virus &Amp; Tumour Progression And Metastasis
COVID-19 Variant Supplement - Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals
Principal investigators: Bell, John C; Ilkow, Carolina S; Lapointe, Réjean; Mahoney, Douglas J
Keywords: Covid-19; Epitopes; Immunity; Infection; Manufacturing; Pre-Clinical; Sars-Cov-2; Vaccine
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.